GlassScriptPhysician profile
Frederick S Kim
NPI 1396322541
$997.79
in general payments reported to CMS, 2019-2025
18 companies · $998 in 2025
The $998 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $997.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $173.32 | 2025 | Wegovy |
| Abbvie INC. | $152.42 | 2025 | |
| Corcept Therapeutics | $127.93 | 2025 | Korlym |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $114.98 | 2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $76.27 | 2025 | Rexulti |
| Tolmar, INC. | $53.66 | 2025 | Jatenzo |
| Lundbeck LLC | $40.82 | 2025 | Vyepti, Rexulti |
| Averitas Pharma INC. | $37.66 | 2025 | Qutenza |
| Glaxosmithkline, LLC. | $29.63 | 2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $29.55 | 2025 | Breztri |
| Sumitomo Pharma America, INC. | $27.14 | 2025 | Gemtesa |
| Pfizer INC. | $24.22 | 2025 | |
| Astellas Pharma US INC | $22.02 | 2025 | Veozah |
| Amgen INC. | $20.82 | 2025 | Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.10 | 2025 | Xifaxan |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $18.82 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $14.31 | 2025 | Zepbound |
| Collegium Pharmaceutical, INC. | $14.12 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.